Theravance Biopharma Aktie
8,10
EUR
+0,05
EUR
+0,62
%
9,18
USD
-0,11
USD
-1,18
%
Werbung
Theravance Biopharma Aktie Analyse
16.06.17 | Theravance Biopharma Overweight | Cantor Fitzgerald | |
11.05.17 | Theravance Biopharma Buy | Needham & Company, LLC | |
21.12.16 | Theravance Biopharma Buy | Needham & Company, LLC |
Werbung
Werbung